Join the SmallCapReview mailing list.

AUPH Aurinia Pharmaceuticals: A late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.  More. 
LPCN Lipocine Inc.: A specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. LPCN's clinical development pipeline includes three development programs.   More.
MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx.    More.
HISP Hispanica International: Is engaged in the distribution of proprietary, licensed and third party Hispanic and Ethnic food and beverages throughout the United States. The Company added over 1,400 retailers to now surpass 2,000 retail locations and will expand to over 5,000 retail locations. More.
Commentary

The Long Small Caps Vs. Short Tech Trade Gets Crowded


Small Caps Get Their Bounce Off Rising Support


Small Cap Opportunities


Biotechs Soared In June, Small Caps Also Outperformed


Watch The Small Caps


Markets
Volume Leaders
Advancers/Decliners
52 Week Highs/Lows
Small-Cap Index
Tools
Check Futures Here
Quotes
Level II Quotes
Stock Screener
Performance by Industry
Pre-Market
After Hours Market
World Markets
Education

 

Visit Our Resources Page

Past Articles Worth Reading

 

 

 

 


 

 

 

 

 

 

 Where Small Cap Stocks Thrive Since 1999                                           

13 Small Caps That Could Shine


Small Caps Look Attractively Priced...

Time To Avoid Staple Stocks And Seek Growth In Small Caps...

High Dividend Small Caps...

It's Time To Go Large In Small Caps...

Small Caps, Big Dividends And Returns Are Here...

Small Cap Growth Hits New 52 Week High...

What Is The S&P Small Cap 600?

The Allure Of Small Caps...

You Feel That? It's The Pain From Owning Tesla...

Strong Small Cap Performance Drives 2nd Quarter Gains... A strong showing by biotech stocks in the second quarter of the year points to a sector back in favor. And in the US at least, the smaller end of the market has benefited from substantial investor attention.

A&F Terminates Buyout Talk, Takes Deep Hit...

How To Trade Small Caps Before They Rally Like They Mean It...

The Oldest Stock Market Indicator Sends A Fresh 'Buy' Signal...

Small Cap Of The Day...

Small Cap IR By The Numbers... Average Small Cap IR budget: $224,000, with $78,000 spent on external services.


Lipocine (LPCN)

Website: www.Lipocine.com

"Developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies."

More on LPCN here...


Myriad Genetics (MYGN)

Website: www.Myriad.com

"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...


Aurinia Pharmaceuticals (AUPH)

 

Website: www.Auriniapharma.com

"Voclosporin has the potential to become a best in class medication and the first approved treatment for LN in the U.S. and Europe."

More on AUPH here...


Hispanica International (HISP)

Website: www.Hidainc.com

"We Bring Latin America And The World To You."

More on HISP here...


Follow Us On

Twitter


Time To Look For Value In Small Cap Stocks


Two Small Caps Buffet Would Buy


7 Fast Growing Small Caps To Look At Now


Making A Case For Small Cap Investing


Small Caps Failing To Target Small Investors


Top 10 Small Cap Dividend Stocks


Small Caps Now Hold The Key To This Market


Small Caps Post Biggest Gain In Three Months


Could This Small Cap Biotech Be The David To Mylan's Epipen Goliath?


3 Small Cap Stocks For the Long Term


So Far, So Good For Small Cap Earnings


7 Tips For Investing In Small Cap Stocks


4 Small Cap Semiconductor Stocks


Hedge Funds Are In Love With Small Caps Again


Lipocine (LPCN) Announces Submission Of SPA ON LPCN 1107, An Oral Alternative For The Prevention Of Preterm, Birth


Last Time This Happened Small Caps Exploded Higher


Playing The Spread


10 Top S&P Small Cap 600 Dividend Dogs See 20% To 100% Net Gains


Dogs Of The Dow


Small Cap Action Is Improving


These Small Cap Tech Stocks May Be Ready For A Breakout


How Shorting A Stock Works


Timing The Market


The Foreign Exchange Market


2017 Review Of Small Cap Stocks



Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.


"A Primer In Small Cap Investing"

SmallCapReview.com® is a leading destination for small-cap picks and news. The Purpose of SmallCapReview.com is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. SmallCapReview.com does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"


 

 

 


 
© 1999-2017 SmallCapReview.com. Any questions or comments regarding this site should be directed to editor@smallcapreview.com